openPR Logo
Press release

Cardiovascular Clinical Trials Market Booming Worldwide with Latest Trend and Future Scope by 2029

11-14-2023 02:57 PM CET | Health & Medicine

Press release from: Orion Market Research

Cardiovascular Clinical Trials Market Booming Worldwide with

The global cardiovascular clinical trials market is anticipated to grow at a CAGR of 9.4% during the forecast period (2023-2030). The key factors for the promising growth of global cardiovascular clinical trials market are increasing number of patients undergoing stroke, technological advancements, enhancement in health facilities, rising healthcare investments, and increasing change in lifestyle related diseases such as obesity which is the major cause of increasing stroke incidences. According to the World Stroke Organization 2022, there are 12.2 million new strokes per year one every 3 seconds around the globe. There are 101 million people around the globe are living with stroke aftermath. this number has almost doubled over the last 30 years. Further, 1 in 4 people will have a stroke in their lifetime this number has increased 50.0% over the last 17 years. Up to 80.0% of strokes and heart attacks happen in people with 63% low or moderate CVD absolute risk. In 2019, 63.0% of stroke happened in people younger than 70 years old. Moreover, growing cases of stroke in various nations across the globe have led to increased need for cardiovascular clinical trials and it has generated maximum revenue in recent times. Some of the key participating global cardiovascular clinical trials market are IQVIA Inc, ICON plc, Medpace, Inc., NoyMed CRO, Eli Lilly and Co. 

The increasing affiliation between the institutions aims to enhance the understanding, prevention, and treatment of cardiovascular disease, and develop new strategies to combat this global health challenge. For instance, in September 2023, Icahn School of Medicine at Mount Sinai signed a memorandum of understanding with the Brazilian Clinical Research Institute (BCRI) to focus on advancing cardiovascular disease research, innovation, and medical education. Under this partnership, Mount Sinai and BCRI launched international research programs and clinical trials on heart disease, including a focus on preventing and treating heart attacks and strokes. Furthermore, in August 2023, Early phase clinical research organization Dr. Vince Clinical Research (DVCR) formed a strategic alliance with Clario for delivering cardiac assessments in clinical trials. The strategic partnership extended access to the Early Precision QT (EPQT) methodology of Clario. Through this partnership, DVCR used the technology with a Wi-Fi-enabled 12-lead telemetry system. This system archives data on-site and directly uploads it to the Cloud-based portal of Clario.

To Request a Sample of our Report on Cardiovascular Clinical Trials Market:  https://www.omrglobal.com/request-sample/cardiovascular-clinical-trials-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segment Covered- 

By Phase
By Study Design
By Indication

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- includes IQVIA Inc, ICON plc, Medpace, Inc., NoyMed CRO, Eli Lilly and Co., and others.

Cardiovascular Clinical Trials Market Report Segment

By Phase

Phase I
Phase II
Phase III
Phase IV

By Study Design

Observational
Interventional
Expanded Access

By Indication

Coronary Artery Disease
Acute Coronary Syndrome
Pulmonary Arterial Hypertension
Ischemic Heart Disease
Stroke
Heart Failure
Others (Cardiac Arrhythmias)

A full Report of Identity Theft Insurance Market is Available @  https://www.omrglobal.com/industry-reports/cardiovascular-clinical-trials-market

Cardiovascular Clinical Trials Market Report Segment by Region

North America                                                                                                           

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America
Middle East and Africa

Company Profiles

Caidya
Cardialysis B.V.,
Cardiovascular Clinical Science Foundation
Clearwater Cardiovascular Consultants
Cytokinetics, Inc.
Eli Lilly and Co.
HonorHealth
Inova Health System
MCRA, LLC
PPD Inc. (Thermo Fisher Scientific Inc.
SGS SA
Syneos Health
Veeda Clinical Research Ltd.
Vial Health Technology, Inc.
Worldwide Clinical Trials

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cardiovascular-clinical-trials-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiovascular Clinical Trials Market Booming Worldwide with Latest Trend and Future Scope by 2029 here

News-ID: 3287183 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Clinical

Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions. Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes. Market Size and Growth The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical